- Home
- ACIU vs XYF Comparison
ACIU vs XYF Comparison
Compare ACIU & XYF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ACIU | XYF |
|---|---|---|
| Founded | 2003 | 2014 |
| Country | Switzerland | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 213.3M | 260.6M |
| IPO Year | 2016 | 2018 |
Fundamental Metrics
Financial Performance| Metric | ACIU | XYF |
|---|---|---|
| Price | $3.09 | $5.88 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $10.00 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 198.1K |
| Earning Date | 11-04-2025 | 11-20-2025 |
| Dividend Yield | N/A | ★ 9.39% |
| EPS Growth | N/A | ★ 49.84 |
| EPS | N/A | ★ 5.72 |
| Revenue | $5,482,957.00 | ★ $1,106,908,607.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $738.95 | N/A |
| P/E Ratio | ★ N/A | $1.04 |
| Revenue Growth | N/A | ★ 47.14 |
| 52 Week Low | $1.43 | $5.81 |
| 52 Week High | $4.00 | $20.36 |
Technical Indicators
Market Signals| Indicator | ACIU | XYF |
|---|---|---|
| Relative Strength Index (RSI) | 53.05 | 23.62 |
| Support Level | $2.87 | $6.36 |
| Resistance Level | $3.21 | $6.74 |
| Average True Range (ATR) | 0.29 | 0.36 |
| MACD | 0.03 | 0.10 |
| Stochastic Oscillator | 46.83 | 5.39 |
Price Performance
Historical ComparisonAbout ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About XYF X Financial each representing six
X Financial is a Cayman Islands-based technology-driven personal finance company. Along with its subsidiaries, the firm provides diversified investment opportunities to investors in China through its wealth management platform, Xiaoying Wealth Management. Loan products offered by the company include Xiaoying Card Loan, Xiaoying Preferred Loan, and Xiaoying Housing Loan. The company generates revenue from loan facilitation service, post-origination service, and guarantee services provided.